Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2022
Aparna Bhaduri, PhD
Understanding the Role of Heterogeneous Cell Types in Pediatric Glioblastoma
Read More
2022
Adam Durbin, MD, PhD
Controlling cell state and chemoresistance in high-risk neuroblastoma
Read More
2022
Christian Hurtz, PhD
DYRK1A is Required to Modulate RAS Signaling Strength in KMT2A-R ALL
Read More
2022
LaQuita Jones, DO
Kinase-independent mechanism of resistance to FLT3 inhibitors in AML
Read More
2022
Yadira Soto-Feliciano, PhD
Targeting chromatin adaptor proteins in pediatric leukemia
Read More
2022
Hatem Soliman, MD
A mixed-methods study to develop a culturally-tailored multi-level intervention to increase the...
Read More
2022
Moon Chen, Jr., PhD
Enhancing Lung Cancer Screening for Eligible Patients through human-centered intervention
Read More
2022
Dipanjan Chowdhury, PhD
Blood-based screening for identification and monitoring of women at elevated risk for...
Read More
2022
Evgeny Izumchenko, M.Sc., Ph.D.
Non-invasive, saliva-based assay for early detection of cancer in patients with high...
Read More
2022
John Ligon, MD
Leveraging RNA-lipid nanoparticle vaccines to induce immune response in metastatic pulmonary osteosarcoma
Read More
2022
Hisham Mohammed, PhD
A DNA methylation predictor for early detection of lethal AML
Read More
2022
Lecia Sequist, MD
Early lung cancer detection through unbiased high throughout deep plasma proteomics
Read More
2022
Arun Sreekumar, PhD
Development of CLIA-certified non-invasive metabolic markers for early detection of prostate cancer...
Read More
2022
Colby Thaxton, MD, PhD
Liquid Biopsy to Measure Novel Biomarker of ImmunoMetabolic Cancer Risk (IMCR)
Read More
2022
Conan Kinsey, MD, PhD
Clinical Translation of combined MAP Kinase and Autophagy Inhibition
Read More
2022
Xiuning Le, MD, PhD
Structure- and lineage-based classification and targeting of resistance in EGFR-mutant NSCLC
Read More